Bamias, Aristotle <br/><br/>
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Dec 2005 
 - 8580-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2005.02.8670  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--therapeutic use<br/>Bone Density Conservation Agents--adverse effects<br/>Bone Neoplasms--drug therapy<br/>Breast Neoplasms--drug therapy<br/>Diphosphonates--adverse effects<br/>Female<br/>Follow-Up Studies<br/>Greece--epidemiology<br/>Humans<br/>Imidazoles--adverse effects<br/>Incidence<br/>Jaw Diseases--chemically induced<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Osteonecrosis--chemically induced<br/>Pamidronate<br/>Prospective Studies<br/>Prostatic Neoplasms--drug therapy<br/>Risk Factors<br/>Time Factors<br/>Treatment Failure<br/>Zoledronic Acid